Germany
Japan
United Kingdom
China
Apolipoprotein E (APOE) (NM_000041) Human Tagged ORF Clone Lentiviral Particle
CAT#: RC200395L1V
- LentiORF®
-
Lenti ORF particles, APOE (Myc-DDK tagged) - Human apolipoprotein E (APOE), 200ul, >10^7 TU/mL
Lentiviral Particles: DDK w/ Puro mGFP mGFP w/ Puro
AAV Particle: DDK
Buy this product and get 50% off on the Lenti RapidTiter kit. Use Code: Rapid50
Product Images
USD 365.00
Specifications
| Product Data | |
| Type | Human Tagged ORF Clone Lentiviral Particle |
| Tag | Myc-DDK |
| Symbol | APOE |
| Synonyms | AD2; APO-E; ApoE4; LDLCQ5; LPG |
| Mammalian Cell Selection | None |
| Vector | pLenti-C-Myc-DDK |
| ACCN | NM_000041 |
| ORF Size | 951 bp |
| Sequence Data |
The ORF insert of this clone is exactly the same as(RC200395).
|
| OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
| OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
| Reference Data | |
| RefSeq | NM_000041.2 |
| RefSeq Size | 1223 bp |
| RefSeq ORF | 954 bp |
| Locus ID | 348 |
| UniProt ID | P02649 |
| Cytogenetics | 19q13.32 |
| Domains | Apolipoprotein |
| Protein Families | Adult stem cells, Druggable Genome, Secreted Protein, Stem cell - Pluripotency |
| Protein Pathways | Alzheimer's disease |
| MW | 36.2 kDa |
| Gene Summary | The protein encoded by this gene is a major apoprotein of the chylomicron. It binds to a specific liver and peripheral cell receptor, and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. This gene maps to chromosome 19 in a cluster with the related apolipoprotein C1 and C2 genes. Mutations in this gene result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants. [provided by RefSeq, Jun 2016] |
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
{0} Product Review(s)
Be the first one to submit a review
